Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2026 14:50 ET | Source: Tevogen Bio Inc

Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical

Tevogen signs LOI to evaluate Apozeal acquisition, advancing U.S.-focused generics strategy with 10 FDA-approved ANDAs and pipeline assets.